Joanna Matowicka-Karna

Diagnostic signi�cance and utility of circulating redox biomarkers in patients with gastric cancer

M. Maciejczyk, A. Zalewska, A. Pryczynicz, 2022 .

Redox Biomarkers – An Effective Tool for Diagnosing COVID-19 Patients and Convalescents

V. Dymicka-Piekarska, M. Maciejczyk, A. Zalewska, 2024, Journal of Inflammation Research.

Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity

V. Dymicka-Piekarska, M. Żendzian-Piotrowska, M. Maciejczyk, 2023, Journal of inflammation research.

Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study

V. Dymicka-Piekarska, M. Żendzian-Piotrowska, M. Maciejczyk, 2024, Frontiers in immunology.

Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19

M. Maciejczyk, A. Zalewska, Blanka Wolszczak-Biedrzycka, 2024, Scientific reports.

The preliminary study suggests an association between NF-ĸB pathway activation and increased plasma 20S proteasome activity in intracranial aneurysm patients

O. Koper-Lenkiewicz, M. Maciejczyk, M. Tylicka, 2024, Scientific reports.